Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin

Authors not listed

University of Michigan · 2005

Abstract

The researchers propose that skin improvements may be seen following a course of Efudex, (5-fluorouracil), a FDA-approved topical therapy (applied directly to the skin). These improvements could be the result of both a reduction of actinic keratoses (small red horny growths or flesh-colored wartlike growths caused by overexposure to ultraviolet radiation or the sun) and improvement of sun-damaged skin. In addition, this research study is being done to determine if the expression of p53, a tumor suppressor gene (its activity stops the formation of tumors), is decreased following Efudex treatment. Mutations (abnormal changes) in the gene, called p53, are associated with a certain type of skin cancer. In addition, p53-mutated genes are known to exist in non-cancerous sun-damaged skin. Thus, the presence of p53 mutations may serve as a marker for both sun damage and an elevated risk of developing skin cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Anonymous. (2005). The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin. <em>University of Michigan</em>. https://clinicaltrials.gov/study/NCT00121511
Vancouver
Anonymous. The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin. University of Michigan. 2005.
BibTeX
@misc{anon2005TheEff, title = {The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin}, author = {Anonymous}, journal = {University of Michigan}, year = {2005}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings